p-hydroxyamphetamine has been researched along with isoproterenol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leopold, IH; Murray, DL | 1 |
| Goi, Y; Hoyano, Y; Kusama, H; Maruyama, I; Maruyama, K; Tatemichi, S; Yamazaki, Y | 1 |
2 other study(ies) available for p-hydroxyamphetamine and isoproterenol
| Article | Year |
|---|---|
Ocular hypotensive action of labetalol.
Topics: Animals; Ethanolamines; Female; Intraocular Pressure; Isoproterenol; Labetalol; Norepinephrine; p-Hydroxyamphetamine; Phenoxybenzamine; Pupil; Rabbits; Sympathectomy; Timolol | 1979 |
Bladder selectivity of the novel β₃-agonist ritobegron (KUC-7483) explored by in vitro and in vivo studies in the rat.
Topics: Acetates; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Agonists; Animals; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Female; Heart Rate; Humans; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Organ Specificity; p-Hydroxyamphetamine; Rats; Rats, Sprague-Dawley; Substrate Specificity; Urinary Bladder; Urinary Bladder, Overactive | 2012 |